PARIS (Reuters) - A U.S. law firm is launching a class action against France's Sanofi over what it calls misleading statements on the safety and... ...http://in.reuters.com/article/2013/12/20/us-sanofi-lemtrada-classaction-idINBRE9BJ0WH20131220?feedType=RSS&feedName=health
LONDON (Reuters) - European regulators on Friday recommended approval of an innovative tuberculosis drug from Johnson & Johnson but postponed a... ...http://in.reuters.com/article/2013/12/20/us-europe-medicines-idINBRE9BJ0KJ20131220?feedType=RSS&feedName=health
Sanofi and leading science-based biopharmaceutical company, Regeneron Pharmaceuticals, Inc. have collaborated with the American College of... ...http://www.pharmabiz.com/NewsDetails.aspx?aid=79384&sid=2
LONDON, Dec. 19, 2013 /PRNewswire/ -- Reportbuyer.com just published a new market research report:AbstractOverviewThe global market for specialty... ...http://in.sys-con.com/node/2905626
LONDON, Dec. 19, 2013 /PRNewswire/ -- Reportbuyer.com just published a new market research report:SummaryGlobalData has released its new Country... ...http://in.sys-con.com/node/2905508
Radisson Blu Hotel New Delhi Paschim...